Infectious Diseases Working Party (IDWP)
Study type:
Study number:
84140169
Type of treatment:
Allogeneic
Autologous
CAR T
Diseases:
Complications: infectious
Short title:
CNS infections after HCT/CAR T: survey
Primary objective:
To evaluate the standard practice regarding the management of CNS infections in patients after HCT and CAR T cell therapy.
Key inclusion criteria:
All EBMT member centres performing allogeneic, autologous HCT or CAR T cell therapy.
Country:
All EBMT member countries
Principal investigator:
Martin Schmidt-Hieber
EBMT Study coordinator:
Nina Knelange
EBMT Study Unit:
Leiden Study Unit
Reason for processing personal data:
Not applicable to surveys
Categories of personal data collected:
Not applicable to surveys
Recipients who may access the data:
Not applicable to surveys
3rd-party processors of Personal Data on behalf of EBMT/Service provider:
Not applicable to surveys
Privacy notices
Article 6 lawful basis for processing personal data:
Not applicable to surveys
Article 9 basis for processing special category data:
Not applicable to surveys
Data Protection Impact Assessments
Rights available to individuals:
Access
Data portability
Rectification
Objection
Deletion
Is a Data Protection Impact Assessment required?:
Not applicable to surveys
Retention Schedule (if possible):
Not applicable to surveys